Embecta (EMBC) Financials

$12.35 +0.06 (+0.49%)

Closing price 05/21/2025 04:00 PM Eastern

Extended Trading

$12.36 +0.01 (+0.04%)

As of 05/21/2025 05:20 PM Eastern

Annual Income Statements for Embecta

This table shows Embecta's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	9/30/2024	9/30/2023	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	78	70	224
Consolidated Net Income / (Loss)	78	70	224
Net Income / (Loss) Continuing Operations	78	70	224
Total Pre-Tax Income	44	106	257
Total Operating Income	167	222	310
Total Gross Profit	735	750	775
Total Revenue	1,123	1,121	1,130
Operating Revenue	1,123	1,121	1,130
Total Cost of Revenue	388	371	355
Operating Cost of Revenue	388	371	355
Total Operating Expenses	568	528	465
Selling, General & Admin Expense	490	441	340
Research & Development Expense	79	85	67
Impairment Charge	0.00	2.50	59
Total Other Income / (Expense), net	-123	-116	-53
Interest & Investment Income	-112	-107	-46
Other Income / (Expense), net	-10	-8.80	-6.80
Income Tax Expense	-34	35	33
Basic Earnings per Share	$1.36	$1.23	$3.92
Weighted Average Basic Shares Outstanding	58.13M	57.33M	57.07M
Diluted Earnings per Share	$1.34	$1.22	$3.89
Weighted Average Diluted Shares Outstanding	58.13M	57.33M	57.07M
Weighted Average Basic & Diluted Shares Outstanding	58.13M	57.33M	57.07M
Cash Dividends to Common per Share	$0.60	-	$0.15

This table shows Embecta's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	24	0.00	15	15	29	20	6.00	15	14	35	-17
Consolidated Net Income / (Loss)	24	0.00	15	15	29	20	6.00	15	14	35	-17
Net Income / (Loss) Continuing Operations	24	0.00	15	15	29	20	6.00	15	14	35	-17
Total Pre-Tax Income	36	-0.70	-7.00	27	9.90	14	5.00	20	25	56	-28
Total Operating Income	63	29	26	56	39	46	26	51	56	89	-3.00
Total Gross Profit	164	157	174	190	185	186	182	190	190	189	177
Total Revenue	259	262	286	273	287	277	282	286	277	276	275
Operating Revenue	259	262	286	273	287	277	282	286	277	276	275
Total Cost of Revenue	95	105	112	82	102	91	100	97	87	87	98
Operating Cost of Revenue	95	105	112	82	102	91	100	97	87	87	98
Total Operating Expenses	101	128	148	134	146	140	156	138	134	100	180
Selling, General & Admin Expense	93	108	128	114	128	120	130	116	112	83	103
Research & Development Expense	8.00	20	20	20	18	20	24	23	22	17	18
Total Other Income / (Expense), net	-27	-29	-33	-29	-29	-31	-21	-31	-31	-33	-25
Interest & Investment Income	-27	-28	-29	-28	-28	-28	-28	-27	-27	-26	-22
Other Income / (Expense), net	-0.40	-1.50	-4.20	-1.10	-1.50	-3.50	6.80	-4.20	-4.30	-7.10	-2.70
Income Tax Expense	12	-0.70	-22	12	-19	-5.80	-1.00	4.90	11	21	-10
Basic Earnings per Share	$0.40	$0.00	$0.26	$0.25	$0.50	$0.35	$0.10	$0.27	$0.24	$0.62	($0.27)
Weighted Average Basic Shares Outstanding	58.44M	58.13M	58.13M	57.70M	57.67M	57.58M	57.33M	57.30M	57.29M	57.27M	57.07M
Diluted Earnings per Share	$0.40	$0.00	$0.24	$0.25	$0.50	$0.35	$0.11	$0.26	$0.24	$0.61	($0.29)
Weighted Average Diluted Shares Outstanding	58.44M	58.13M	58.13M	57.70M	57.67M	57.58M	57.33M	57.30M	57.29M	57.27M	57.07M
Weighted Average Basic & Diluted Shares Outstanding	58.44M	58.13M	58.13M	57.70M	57.67M	57.58M	57.33M	57.30M	57.29M	57.27M	57.07M

This table details how cash moves in and out of Embecta's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021
Net Change in Cash & Equivalents	-52	-4.40	331	0.00
Net Cash From Operating Activities	36	68	412	456
Net Cash From Continuing Operating Activities	36	68	412	456
Net Income / (Loss) Continuing Operations	78	70	224	415
Consolidated Net Income / (Loss)	78	70	224	415
Depreciation Expense	36	33	32	38
Amortization Expense	13	6.40	3.20	0.00
Non-Cash Adjustments To Reconcile Net Income	85	0.80	31	27
Changes in Operating Assets and Liabilities, net	-177	-43	123	-23
Net Cash From Investing Activities	-16	-27	-24	-39
Net Cash From Continuing Investing Activities	-16	-27	-24	-39
Purchase of Property, Plant & Equipment	-16	-27	-24	-37
Acquisitions	0.00	0.00	-0.40	-2.40
Net Cash From Financing Activities	-73	-49	-48	-417
Net Cash From Continuing Financing Activities	-73	-49	-48	-417
Repayment of Debt	-35	-9.50	-44	0.00
Payment of Dividends	-35	-34	-8.60	0.00
Issuance of Debt	0.00	0.00	1,450	0.00
Other Financing Activities, net	-4.30	-4.80	-1,446	-417
Effect of Exchange Rate Changes	1.20	3.10	-9.30	0.00

This table details how cash moves in and out of Embecta's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-4.40	-58	-7.60	-25	7.80	-28	9.10	-29	-39	54	39
Net Cash From Operating Activities	32	-5.30	27	-2.10	24	-13	30	-9.30	-13	60	58
Net Cash From Continuing Operating Activities	32	-5.30	27	-2.10	24	-13	30	-9.30	-13	60	58
Net Income / (Loss) Continuing Operations	24	0.00	15	15	29	20	6.00	15	14	35	-17
Consolidated Net Income / (Loss)	24	0.00	15	15	29	20	6.00	15	14	35	-17
Depreciation Expense	9.00	9.40	9.50	8.90	9.00	8.80	9.30	8.10	8.00	7.20	7.50
Amortization Expense	4.70	4.60	4.60	3.80	2.80	2.00	1.60	1.60	1.60	1.60	1.30
Non-Cash Adjustments To Reconcile Net Income	6.80	35	16	-8.80	54	24	39	-34	0.20	-4.00	110
Changes in Operating Assets and Liabilities, net	-12	-54	-18	-21	-70	-68	-26	0.20	-37	20	-43
Net Cash From Investing Activities	-0.10	-1.50	-	-9.70	-3.40	-2.70	-9.20	-6.80	-5.80	-4.70	-8.60
Net Cash From Continuing Investing Activities	-0.10	-1.50	-	-9.70	-3.40	-2.70	-9.20	-6.80	-5.80	-4.70	-8.60
Purchase of Property, Plant & Equipment	-0.10	-1.50	-	-9.70	-3.40	-2.70	-9.20	-6.80	-5.80	-4.70	-8.60
Net Cash From Financing Activities	-37	-45	-37	-12	-12	-14	-9.70	-12	-21	-6.10	-7.10
Net Cash From Continuing Financing Activities	-37	-45	-37	-12	-12	-14	-9.70	-12	-21	-6.10	-7.10
Repayment of Debt	-27	-32	-27	-2.40	-2.40	-2.40	-2.40	-2.30	-2.40	-2.40	-8.00
Payment of Dividends	-8.70	-8.80	-8.70	-8.60	-8.60	-8.60	-8.60	-8.60	-17	0.00	-8.60
Other Financing Activities, net	-1.20	-4.00	-0.50	-0.50	-0.80	-2.50	1.30	-1.30	-1.10	-3.70	9.50
Effect of Exchange Rate Changes	1.20	-5.50	2.40	-1.40	-1.30	1.50	-1.60	-0.70	0.70	4.70	-3.70

This table presents Embecta's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	9/30/2024	9/30/2023	9/30/2022
Total Assets	1,285	1,214	1,086
Total Current Assets	761	749	665
Cash & Equivalents	268	326	331
Restricted Cash	6.70	0.20	-
Accounts Receivable	247	159	133
Inventories, net	172	152	123
Other Current Assets	69	111	78
Plant, Property, & Equipment, net	290	300	302
Total Noncurrent Assets	234	165	120
Goodwill	24	25	25
Noncurrent Deferred & Refundable Income Taxes	210	140	96
Total Liabilities & Shareholders' Equity	1,285	1,214	1,086
Total Liabilities	2,024	2,036	1,978
Total Current Liabilities	374	354	301
Short-Term Debt	9.50	9.50	9.50
Accounts Payable	134	127	108
Accrued Expenses	134	118	104
Current Deferred & Payable Income Tax Liabilities	27	34	27
Current Employee Benefit Liabilities	67	62	49
Other Current Liabilities	3.40	3.60	3.60
Total Noncurrent Liabilities	1,650	1,683	1,677
Long-Term Debt	1,565	1,594	1,598
Noncurrent Deferred & Payable Income Tax Liabilities	54	57	46
Other Noncurrent Operating Liabilities	30	32	33
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-738	-822	-891
Total Preferred & Common Equity	-738	-822	-891
Total Common Equity	-738	-822	-891
Common Stock	53	29	11
Retained Earnings	-499	-541	-577
Accumulated Other Comprehensive Income / (Loss)	-293	-309	-325

This table presents Embecta's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	12/31/2024	6/30/2024	3/31/2024	12/31/2023	6/30/2023	3/31/2023	12/31/2022	6/30/2022
Total Assets	1,120	1,150	1,268	1,200	1,218	1,252	1,210	1,197	1,050
Total Current Assets	643	667	781	710	720	788	756	762	581
Cash & Equivalents	209	210	275	300	299	317	346	385	292
Restricted Cash	3.00	6.70	6.70	6.70	-	-	-	-	-
Accounts Receivable	203	221	243	167	206	190	153	143	119
Inventories, net	169	169	186	153	149	170	158	143	130
Other Current Assets	59	61	70	83	65	110	100	90	39
Plant, Property, & Equipment, net	257	259	291	293	301	309	314	314	376
Total Noncurrent Assets	219	223	195	196	197	156	140	121	94
Goodwill	23	23	24	24	24	25	24	24	25
Noncurrent Deferred & Refundable Income Taxes	196	200	171	172	173	131	116	97	-
Total Liabilities & Shareholders' Equity	1,120	1,150	1,268	1,200	1,218	1,252	1,210	1,197	1,050
Total Liabilities	1,856	1,918	2,031	1,969	2,011	2,062	2,033	2,033	1,897
Total Current Liabilities	259	298	371	310	327	386	358	370	229
Short-Term Debt	9.50	9.50	9.50	9.50	9.50	9.50	9.50	9.50	9.50
Accounts Payable	80	116	119	91	100	125	127	107	64
Accrued Expenses	123	127	142	120	122	160	147	157	90
Current Deferred & Payable Income Tax Liabilities	0.00	0.00	41	28	34	35	36	45	20
Current Employee Benefit Liabilities	44	43	56	59	57	52	36	49	41
Other Current Liabilities	3.40	3.40	3.40	3.70	3.70	3.60	3.60	3.60	3.60
Total Noncurrent Liabilities	1,597	1,620	1,661	1,659	1,685	1,676	1,675	1,663	1,669
Long-Term Debt	1,509	1,535	1,591	1,592	1,593	1,595	1,596	1,597	1,599
Noncurrent Deferred & Payable Income Tax Liabilities	59	56	39	36	61	49	47	33	37
Other Noncurrent Operating Liabilities	30	30	31	31	31	32	32	32	33
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-736	-769	-764	-770	-794	-809	-823	-836	-848
Total Preferred & Common Equity	-736	-769	-764	-770	-794	-809	-823	-836	-848
Total Common Equity	-736	-769	-764	-770	-794	-809	-823	-836	-848
Common Stock	66	59	47	40	34	24	19	13	6.40
Retained Earnings	-494	-508	-504	-510	-530	-539	-545	-551	-556
Accumulated Other Comprehensive Income / (Loss)	-308	-320	-306	-300	-298	-295	-296	-299	-298

This table displays calculated financial ratios and metrics derived from Embecta's official financial filings.

Metric	2024	2023	2022
Period end date	9/30/2024	9/30/2023	9/30/2022
Growth Metrics	-	-	-
Revenue Growth	0.21%	-0.77%	-3.07%
EBITDA Growth	-18.20%	-25.47%	-36.67%
EBIT Growth	-26.42%	-29.76%	-38.82%
NOPAT Growth	100.29%	-45.32%	-34.58%
Net Income Growth	11.22%	-68.52%	-46.09%
EPS Growth	9.84%	-68.64%	-46.57%
Operating Cash Flow Growth	-47.27%	-83.58%	-9.66%
Free Cash Flow Firm Growth	142.68%	-83.79%	363.17%
Invested Capital Growth	23.53%	18.14%	-35.17%
Revenue Q/Q Growth	0.38%	0.66%	0.00%
EBITDA Q/Q Growth	-3.47%	19.12%	0.00%
EBIT Q/Q Growth	-6.34%	21.96%	0.00%
NOPAT Q/Q Growth	43.18%	18.73%	0.00%
Net Income Q/Q Growth	12.34%	49.15%	0.00%
EPS Q/Q Growth	10.74%	48.78%	0.00%
Operating Cash Flow Q/Q Growth	-7.75%	-29.55%	-6.25%
Free Cash Flow Firm Q/Q Growth	45.73%	0.00%	0.00%
Invested Capital Q/Q Growth	1.35%	-4.71%	0.00%
Profitability Metrics	-	-	-
Gross Margin	65.46%	66.91%	68.61%
EBITDA Margin	18.33%	22.46%	29.90%
Operating Margin	14.85%	19.76%	27.41%
EBIT Margin	13.93%	18.98%	26.81%
Profit (Net Income) Margin	6.97%	6.28%	19.80%
Tax Burden Percent	177.15%	66.60%	87.14%
Interest Burden Percent	28.24%	49.69%	84.74%
Effective Tax Rate	-77.15%	33.40%	12.86%
Return on Invested Capital (ROIC)	58.08%	35.10%	55.08%
ROIC Less NNEP Spread (ROIC-NNEP)	41.23%	29.06%	47.85%
Return on Net Nonoperating Assets (RNNOA)	-68.12%	-43.32%	-205.60%
Return on Equity (ROE)	-10.04%	-8.22%	-150.52%
Cash Return on Invested Capital (CROIC)	37.03%	18.47%	97.75%
Operating Return on Assets (OROA)	12.52%	18.49%	32.31%
Return on Assets (ROA)	6.26%	6.12%	23.86%
Return on Common Equity (ROCE)	-10.04%	-8.22%	-150.52%
Return on Equity Simple (ROE_SIMPLE)	-10.61%	-8.57%	-25.08%
Net Operating Profit after Tax (NOPAT)	295	148	270
NOPAT Margin	26.31%	13.16%	23.89%
Net Nonoperating Expense Percent (NNEP)	16.85%	6.04%	7.23%
Return On Investment Capital (ROIC_SIMPLE)	35.32%	18.87%	37.67%
Cost of Revenue to Revenue	34.54%	33.09%	31.39%
SG&A Expenses to Revenue	43.59%	39.32%	30.06%
R&D to Revenue	7.02%	7.60%	5.92%
Operating Expenses to Revenue	50.61%	47.14%	41.20%
Earnings before Interest and Taxes (EBIT)	157	213	303
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	206	252	338
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.72	0.73	1.37
Price to Earnings (P/E)	10.31	11.67	6.92
Dividend Yield	4.29%	4.18%	0.56%
Earnings Yield	9.70%	8.57%	14.44%
Enterprise Value to Invested Capital (EV/IC)	3.75	4.61	7.33
Enterprise Value to Revenue (EV/Rev)	1.88	1.87	2.50
Enterprise Value to EBITDA (EV/EBITDA)	10.24	8.34	8.37
Enterprise Value to EBIT (EV/EBIT)	13.47	9.87	9.33
Enterprise Value to NOPAT (EV/NOPAT)	7.13	14.23	10.47
Enterprise Value to Operating Cash Flow (EV/OCF)	59.05	31.00	6.85
Enterprise Value to Free Cash Flow (EV/FCFF)	11.19	27.03	5.90
Leverage & Solvency	-	-	-
Debt to Equity	-2.13	-1.95	-1.80
Long-Term Debt to Equity	-2.12	-1.94	-1.79
Financial Leverage	-1.65	-1.49	-4.30
Leverage Ratio	-1.60	-1.34	-6.31
Compound Leverage Factor	-0.45	-0.67	-5.35
Debt to Total Capital	188.26%	205.12%	224.46%
Short-Term Debt to Total Capital	1.14%	1.22%	1.33%
Long-Term Debt to Total Capital	187.12%	203.90%	223.14%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	-88.26%	-105.12%	-124.46%
Debt to EBITDA	7.65	6.37	4.76
Net Debt to EBITDA	6.32	5.07	3.78
Long-Term Debt to EBITDA	7.60	6.33	4.73
Debt to NOPAT	5.33	10.87	5.96
Net Debt to NOPAT	4.40	8.66	4.73
Long-Term Debt to NOPAT	5.30	10.80	5.92
Altman Z-Score	1.33	1.51	2.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	2.03	2.12	2.21
Quick Ratio	1.38	1.37	1.54
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	188	78	479
Operating Cash Flow to CapEx	225.95%	255.47%	1,746.61%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.90	0.97	1.21
Accounts Receivable Turnover	5.53	7.67	7.96
Inventory Turnover	2.40	2.70	2.95
Fixed Asset Turnover	3.80	3.72	3.00
Accounts Payable Turnover	2.98	3.16	4.38
Days Sales Outstanding (DSO)	65.96	47.58	45.84
Days Inventory Outstanding (DIO)	152.25	135.26	123.93
Days Payable Outstanding (DPO)	122.37	115.38	83.43
Cash Conversion Cycle (CCC)	95.83	67.46	86.34
Capital & Investment Metrics	-	-	-
Invested Capital	562	455	385
Invested Capital Turnover	2.21	2.67	2.31
Increase / (Decrease) in Invested Capital	107	70	-209
Enterprise Value (EV)	2,108	2,099	2,825
Market Capitalization	807	822	1,548
Book Value per Share	($12.80)	($14.34)	($15.41)
Tangible Book Value per Share	($13.21)	($14.77)	($15.84)
Total Capital	837	782	716
Total Debt	1,575	1,603	1,608
Total Long-Term Debt	1,565	1,594	1,598
Net Debt	1,301	1,277	1,277
Capital Expenditures (CapEx)	16	27	24
Debt-free, Cash-free Net Working Capital (DFCFNWC)	122	79	42
Debt-free Net Working Capital (DFNWC)	397	405	373
Net Working Capital (NWC)	387	396	364
Net Nonoperating Expense (NNE)	217	77	46
Net Nonoperating Obligations (NNO)	1,301	1,277	1,277
Total Depreciation and Amortization (D&A)	49	39	35
Debt-free, Cash-free Net Working Capital to Revenue	10.89%	7.01%	3.75%
Debt-free Net Working Capital to Revenue	35.30%	36.14%	33.04%
Net Working Capital to Revenue	34.46%	35.30%	32.20%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$1.36	$1.23	$3.92
Adjusted Weighted Average Basic Shares Outstanding	58.13M	57.33M	57.07M
Adjusted Diluted Earnings per Share	$1.34	$1.22	$3.89
Adjusted Weighted Average Diluted Shares Outstanding	58.13M	57.33M	57.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	58.13M	57.33M	57.07M
Normalized Net Operating Profit after Tax (NOPAT)	117	149	321
Normalized NOPAT Margin	10.40%	13.31%	28.43%
Pre Tax Income Margin	3.94%	9.43%	22.72%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	44.06%	48.86%	3.85%
Augmented Payout Ratio	44.06%	48.86%	3.85%

This table displays calculated financial ratios and metrics derived from Embecta's official financial filings.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-9.82%	-5.55%	1.49%	-4.75%	3.64%	0.58%	2.66%	-1.72%	0.95%	-4.70%	0.00%
EBITDA Growth	53.94%	-21.97%	-17.01%	18.84%	-18.72%	-41.66%	1,303.23%	-45.38%	-42.33%	-27.60%	0.00%
EBIT Growth	65.78%	-35.24%	-32.52%	16.35%	-26.51%	-48.59%	671.93%	-49.41%	-48.08%	-29.93%	0.00%
NOPAT Growth	-63.92%	-68.59%	-40.76%	-21.55%	260.17%	14.78%	1,574.29%	-52.88%	-62.10%	-43.61%	0.00%
Net Income Growth	-18.69%	-100.00%	143.33%	-3.29%	106.43%	-42.90%	134.88%	-75.64%	-82.41%	-64.37%	0.00%
EPS Growth	-20.00%	-100.00%	118.18%	-3.85%	108.33%	-42.62%	137.93%	-75.70%	-82.61%	-64.74%	0.00%
Operating Cash Flow Growth	30.86%	59.54%	-10.14%	77.42%	286.92%	-121.69%	-48.97%	-128.35%	-107.12%	-56.48%	-32.16%
Free Cash Flow Firm Growth	-114.03%	53.38%	-127.94%	-256.10%	106.36%	81.51%	0.00%	107.74%	0.00%	0.00%	0.00%
Invested Capital Growth	8.55%	9.51%	23.53%	16.14%	20.32%	32.42%	18.14%	1.90%	0.00%	0.00%	0.00%
Revenue Q/Q Growth	-1.11%	-8.46%	4.99%	-5.12%	3.57%	-1.63%	-1.47%	3.25%	0.51%	0.40%	-5.67%
EBITDA Q/Q Growth	84.95%	14.13%	-46.52%	36.36%	-6.25%	21.38%	-23.42%	-6.73%	-32.71%	2,819.35%	-97.02%
EBIT Q/Q Growth	129.78%	23.64%	-59.85%	45.36%	-10.24%	28.83%	-30.79%	-8.19%	-37.21%	1,533.33%	-106.12%
NOPAT Q/Q Growth	105.52%	9.54%	-39.74%	-73.40%	78.93%	106.57%	-20.19%	22.10%	-42.98%	2,753.22%	-102.55%
Net Income Q/Q Growth	0.00%	-100.00%	-0.68%	-49.13%	43.78%	235.00%	-60.53%	8.57%	-60.23%	304.65%	-127.56%
EPS Q/Q Growth	0.00%	-100.00%	-4.00%	-50.00%	42.86%	218.18%	-57.69%	8.33%	-60.66%	310.34%	-127.10%
Operating Cash Flow Q/Q Growth	700.00%	-119.92%	1,366.67%	-108.64%	285.50%	-144.26%	418.28%	28.46%	-121.52%	4.14%	76.83%
Free Cash Flow Firm Q/Q Growth	87.29%	67.99%	-90.20%	-281.35%	142.22%	-56.51%	-230.26%	107.39%	-22.80%	0.00%	100.00%
Invested Capital Q/Q Growth	2.04%	-0.64%	1.35%	5.64%	2.94%	12.08%	-4.71%	9.44%	13.29%	0.00%	-17.81%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	63.36%	59.98%	60.75%	69.76%	64.55%	67.04%	64.49%	66.24%	68.50%	68.48%	64.42%
EBITDA Margin	29.42%	15.73%	12.62%	24.77%	17.24%	19.04%	15.43%	19.85%	21.98%	32.83%	1.13%
Operating Margin	24.29%	10.96%	9.16%	20.51%	13.65%	16.41%	9.15%	17.93%	20.07%	32.21%	-1.09%
EBIT Margin	24.13%	10.39%	7.69%	20.11%	13.13%	15.15%	11.56%	16.46%	18.51%	29.63%	-2.08%
Profit (Net Income) Margin	9.07%	0.00%	5.10%	5.39%	10.06%	7.25%	2.13%	5.31%	5.05%	12.77%	-6.26%
Tax Burden Percent	65.64%	0.00%	-208.57%	54.44%	291.92%	140.56%	120.00%	75.62%	57.14%	62.75%	62.55%
Interest Burden Percent	57.28%	-2.57%	-31.82%	49.27%	26.26%	34.05%	15.34%	42.68%	47.76%	68.67%	482.46%
Effective Tax Rate	34.36%	0.00%	0.00%	45.56%	-191.92%	-40.56%	-20.00%	24.38%	42.86%	37.25%	0.00%
Return on Invested Capital (ROIC)	31.42%	15.90%	14.15%	24.21%	93.84%	57.81%	29.29%	31.90%	58.76%	117.06%	-2.24%
ROIC Less NNEP Spread (ROIC-NNEP)	30.06%	14.37%	13.86%	23.00%	87.14%	54.34%	27.34%	30.09%	55.94%	113.70%	-3.42%
Return on Net Nonoperating Assets (RNNOA)	-51.92%	-24.20%	-22.90%	-38.09%	-139.78%	-84.20%	-40.75%	-47.28%	-85.62%	-166.10%	4.90%
Return on Equity (ROE)	-20.49%	-8.31%	-8.75%	-13.89%	-45.94%	-26.39%	-11.46%	-15.38%	-26.86%	-49.04%	2.66%
Cash Return on Invested Capital (CROIC)	22.19%	46.87%	37.03%	25.04%	29.47%	6.55%	18.47%	0.00%	0.00%	0.00%	124.26%
Operating Return on Assets (OROA)	22.46%	9.72%	6.91%	17.86%	12.34%	14.08%	11.27%	15.93%	17.11%	27.63%	-2.50%
Return on Assets (ROA)	8.44%	0.00%	4.59%	4.79%	9.46%	6.74%	2.07%	5.14%	4.67%	11.90%	-7.55%
Return on Common Equity (ROCE)	-20.49%	-8.31%	-8.75%	-13.89%	-45.94%	-26.39%	-11.46%	-15.38%	-26.86%	-49.04%	2.66%
Return on Equity Simple (ROE_SIMPLE)	-7.17%	-7.57%	0.00%	-9.13%	-9.12%	-6.97%	0.00%	-5.83%	-11.48%	-19.14%	0.00%
Net Operating Profit after Tax (NOPAT)	41	20	18	30	114	64	31	39	32	56	-2.10
NOPAT Margin	15.94%	7.67%	6.41%	11.17%	39.84%	23.06%	10.98%	13.56%	11.47%	20.21%	-0.76%
Net Nonoperating Expense Percent (NNEP)	1.37%	1.53%	0.29%	1.21%	6.70%	3.47%	1.95%	1.81%	2.82%	3.36%	1.18%
Return On Investment Capital (ROIC_SIMPLE)	5.28%	2.59%	2.19%	-	-	7.91%	3.96%	-	-	-	-0.29%
Cost of Revenue to Revenue	36.64%	40.02%	39.25%	30.24%	35.45%	32.96%	35.51%	33.76%	31.50%	31.52%	35.58%
SG&A Expenses to Revenue	35.98%	41.28%	44.67%	41.76%	44.50%	43.35%	46.08%	40.41%	40.45%	30.14%	37.55%
R&D to Revenue	3.09%	7.75%	6.92%	7.49%	6.41%	7.28%	8.37%	7.90%	7.98%	6.13%	6.52%
Operating Expenses to Revenue	39.07%	49.03%	51.59%	49.25%	50.91%	50.63%	55.34%	48.30%	48.43%	36.27%	65.51%
Earnings before Interest and Taxes (EBIT)	63	27	22	55	38	42	33	47	51	82	-5.70
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	76	41	36	68	50	53	44	57	61	91	3.10
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.69	1.08	0.72	0.64	0.67	0.93	0.73	1.07	1.38	1.23	1.37
Price to Earnings (P/E)	14.04	20.63	10.31	10.34	10.76	18.84	11.67	25.22	16.32	8.59	6.92
Dividend Yield	4.71%	2.91%	4.29%	4.80%	4.57%	4.12%	4.18%	2.89%	1.67%	1.25%	0.56%
Earnings Yield	7.12%	4.85%	9.70%	9.67%	9.29%	5.31%	8.57%	3.96%	6.13%	11.64%	14.44%
Enterprise Value to Invested Capital (EV/IC)	3.59	4.52	3.75	3.68	3.90	4.60	4.61	5.19	6.42	6.74	7.33
Enterprise Value to Revenue (EV/Rev)	1.90	2.28	1.88	1.82	1.81	2.09	1.87	2.23	2.50	2.33	2.50
Enterprise Value to EBITDA (EV/EBITDA)	9.26	13.01	10.24	9.56	10.12	10.96	8.34	11.73	10.83	8.56	8.37
Enterprise Value to EBIT (EV/EBIT)	12.30	17.84	13.47	12.20	12.86	13.56	9.87	14.21	12.70	9.69	9.33
Enterprise Value to NOPAT (EV/NOPAT)	12.30	8.46	7.13	9.88	8.90	15.21	14.23	19.94	15.76	11.29	10.47
Enterprise Value to Operating Cash Flow (EV/OCF)	40.15	58.11	59.05	52.70	65.08	0.00	31.00	25.78	20.26	7.78	6.85
Enterprise Value to Free Cash Flow (EV/FCFF)	16.85	10.09	11.19	15.78	14.47	80.01	27.03	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-2.06	-2.01	-2.13	-2.10	-2.08	-2.02	-1.95	-1.98	-1.95	-1.92	-1.80
Long-Term Debt to Equity	-2.05	-2.00	-2.12	-2.08	-2.07	-2.01	-1.94	-1.97	-1.94	-1.91	-1.79
Financial Leverage	-1.73	-1.68	-1.65	-1.66	-1.60	-1.55	-1.49	-1.57	-1.53	-1.46	-1.43
Leverage Ratio	-1.54	-1.52	-1.60	-1.60	-1.51	-1.48	-1.34	-1.39	-1.47	-1.43	-6.31
Compound Leverage Factor	-0.88	0.04	0.51	-0.79	-0.40	-0.50	-0.21	-0.59	-0.70	-0.98	-30.44
Debt to Total Capital	194.10%	199.15%	188.26%	191.29%	192.53%	198.10%	205.12%	201.80%	205.07%	208.51%	224.46%
Short-Term Debt to Total Capital	1.21%	1.23%	1.14%	1.14%	1.14%	1.17%	1.22%	1.19%	1.21%	1.23%	1.33%
Long-Term Debt to Total Capital	192.88%	197.92%	187.12%	190.15%	191.39%	196.92%	203.90%	200.60%	203.86%	207.28%	223.14%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-94.10%	-99.15%	-88.26%	-91.29%	-92.53%	-98.10%	-105.12%	-101.80%	-105.07%	-108.51%	-124.46%
Debt to EBITDA	6.87	7.95	7.65	7.50	7.90	7.49	6.37	7.59	6.21	5.30	4.76
Net Debt to EBITDA	5.91	6.83	6.32	6.18	6.39	6.09	5.07	6.09	4.87	4.03	3.78
Long-Term Debt to EBITDA	6.83	7.90	7.60	7.46	7.86	7.44	6.33	7.55	6.17	5.27	4.73
Debt to NOPAT	9.12	5.17	5.33	7.75	6.95	10.39	10.87	12.91	9.04	6.99	5.96
Net Debt to NOPAT	7.85	4.44	4.40	6.39	5.62	8.45	8.66	10.36	7.09	5.31	4.73
Long-Term Debt to NOPAT	9.07	5.13	5.30	7.71	6.91	10.33	10.80	12.84	8.98	6.95	5.92
Altman Z-Score	1.18	1.18	0.99	1.07	1.08	1.12	1.02	1.14	1.28	1.31	1.15
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.48	2.24	2.03	2.11	2.29	2.20	2.12	2.04	2.11	2.06	2.21
Quick Ratio	1.59	1.44	1.38	1.40	1.50	1.55	1.37	1.32	1.40	1.43	1.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-3.61	-28	-89	-47	26	-61	-39	30	-405	-330	0.00
Operating Cash Flow to CapEx	31,800.00%	-353.33%	0.00%	-21.65%	714.71%	-485.19%	321.74%	-136.76%	-224.14%	1,285.11%	674.42%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.93	0.94	0.90	0.89	0.94	0.93	0.97	0.97	0.92	0.93	1.21
Accounts Receivable Turnover	5.84	5.19	5.53	5.16	7.08	6.42	7.67	7.20	7.32	7.79	7.96
Inventory Turnover	2.45	2.52	2.40	2.11	2.51	2.57	2.70	2.45	2.28	2.48	2.95
Fixed Asset Turnover	3.92	3.95	3.80	3.73	3.73	3.65	3.72	3.25	3.57	3.55	3.00
Accounts Payable Turnover	4.62	3.73	2.98	3.09	3.58	3.63	3.16	3.90	2.84	3.33	4.38
Days Sales Outstanding (DSO)	62.48	70.33	65.96	70.71	51.52	56.86	47.58	50.69	49.83	46.87	45.84
Days Inventory Outstanding (DIO)	149.18	144.75	152.25	172.88	145.48	142.25	135.26	148.87	159.74	146.98	123.93
Days Payable Outstanding (DPO)	78.94	97.91	122.37	118.14	101.99	100.44	115.38	93.60	128.53	109.57	83.43
Cash Conversion Cycle (CCC)	132.73	117.18	95.83	125.45	95.00	98.67	67.46	105.96	81.05	84.28	86.34
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	570	559	562	555	525	510	455	478	437	385	385
Invested Capital Turnover	1.97	2.07	2.21	2.17	2.36	2.51	2.67	2.35	5.12	5.79	2.93
Increase / (Decrease) in Invested Capital	45	49	107	77	89	125	70	8.90	437	385	0.00
Enterprise Value (EV)	2,048	2,528	2,108	2,039	2,050	2,346	2,099	2,478	2,800	2,596	2,825
Market Capitalization	741	1,200	807	721	755	1,042	822	1,191	1,541	1,375	1,548
Book Value per Share	($12.66)	($13.23)	($12.80)	($13.24)	($13.37)	($13.78)	($14.34)	($14.13)	($14.36)	($14.65)	($15.41)
Tangible Book Value per Share	($13.06)	($13.63)	($13.21)	($13.66)	($13.78)	($14.20)	($14.77)	($14.56)	($14.78)	($15.08)	($15.84)
Total Capital	782	775	837	837	832	809	782	795	783	771	716
Total Debt	1,519	1,544	1,575	1,600	1,601	1,602	1,603	1,605	1,606	1,607	1,608
Total Long-Term Debt	1,509	1,535	1,565	1,591	1,592	1,593	1,594	1,595	1,596	1,597	1,598
Net Debt	1,306	1,328	1,301	1,319	1,295	1,304	1,277	1,287	1,259	1,221	1,277
Capital Expenditures (CapEx)	0.10	1.50	0.00	9.70	3.40	2.70	9.20	6.80	5.80	4.70	8.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)	181	162	122	138	103	104	79	94	62	16	42
Debt-free Net Working Capital (DFNWC)	394	379	397	420	409	402	405	411	408	401	373
Net Working Capital (NWC)	384	369	387	410	400	393	396	402	399	391	364
Net Nonoperating Expense (NNE)	18	20	3.74	16	86	44	25	24	18	21	15
Net Nonoperating Obligations (NNO)	1,306	1,328	1,301	1,319	1,295	1,304	1,277	1,287	1,259	1,221	1,277
Total Depreciation and Amortization (D&A)	14	14	14	13	12	11	11	9.70	9.60	8.80	8.80
Debt-free, Cash-free Net Working Capital to Revenue	16.79%	14.61%	10.89%	12.34%	9.06%	9.24%	7.01%	8.42%	5.52%	1.41%	3.75%
Debt-free Net Working Capital to Revenue	36.46%	34.17%	35.30%	37.53%	36.12%	35.85%	36.14%	36.93%	36.49%	35.93%	33.04%
Net Working Capital to Revenue	35.58%	33.31%	34.46%	36.68%	35.28%	35.01%	35.30%	36.08%	35.64%	35.07%	32.20%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.40	$0.00	$0.26	$0.25	$0.50	$0.35	$0.10	$0.27	$0.24	$0.62	($0.27)
Adjusted Weighted Average Basic Shares Outstanding	58.44M	58.13M	58.13M	57.70M	57.67M	57.58M	57.33M	57.30M	57.29M	57.27M	57.07M
Adjusted Diluted Earnings per Share	$0.40	$0.00	$0.24	$0.25	$0.50	$0.35	$0.11	$0.26	$0.24	$0.61	($0.29)
Adjusted Weighted Average Diluted Shares Outstanding	58.44M	58.13M	58.13M	57.70M	57.67M	57.58M	57.33M	57.30M	57.29M	57.27M	57.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	58.44M	58.13M	58.13M	57.70M	57.67M	57.58M	57.33M	57.30M	57.29M	57.27M	57.07M
Normalized Net Operating Profit after Tax (NOPAT)	41	20	18	30	27	32	18	39	32	56	-2.10
Normalized NOPAT Margin	15.94%	7.67%	6.41%	11.17%	9.55%	11.49%	6.41%	13.56%	11.47%	20.21%	-0.76%
Pre Tax Income Margin	13.82%	-0.27%	-2.45%	9.91%	3.45%	5.16%	1.77%	7.03%	8.84%	20.35%	-10.01%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	65.91%	59.62%	44.06%	49.35%	49.00%	77.76%	48.86%	72.88%	27.33%	0.00%	3.85%
Augmented Payout Ratio	65.91%	59.62%	44.06%	49.35%	49.00%	77.76%	48.86%	72.88%	27.33%	0.00%	3.85%

Frequently Asked Questions About Embecta's Financials

When does Embecta's fiscal year end?

According to the most recent income statement we have on file, Embecta's financial year ends in September. Their financial year 2024 ended on September 30, 2024.

How has Embecta's net income changed over the last 2 years?

Embecta's net income appears to be on a downward trend, with a most recent value of $78.30 million in 2024, falling from $223.60 million in 2022. The previous period was $70.40 million in 2023. View Embecta's forecast to see where analysts expect Embecta to go next.

What is Embecta's operating income?

Embecta's total operating income in 2024 was $166.80 million, based on the following breakdown:

Total Gross Profit: $735.20 million
Total Operating Expenses: $568.40 million

How has Embecta revenue changed over the last 2 years?

Over the last 2 years, Embecta's total revenue changed from $1.13 billion in 2022 to $1.12 billion in 2024, a change of -0.6%.

How much debt does Embecta have?

Embecta's total liabilities were at $2.02 billion at the end of 2024, a 0.6% decrease from 2023, and a 2.3% increase since 2022.

How much cash does Embecta have?

In the past 2 years, Embecta's cash and equivalents has ranged from $267.50 million in 2024 to $330.90 million in 2022, and is currently $267.50 million as of their latest financial filing in 2024.

How has Embecta's book value per share changed over the last 2 years?

Over the last 2 years, Embecta's book value per share changed from -15.41 in 2022 to -12.80 in 2024, a change of -17.0%.

Related Companies

This page (NASDAQ:EMBC) was last updated on 5/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Embecta (EMBC) Financials

Frequently Asked Questions About Embecta's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Embecta (EMBC) Financials

Annual Income Statements for Embecta

Quarterly Income Statements for Embecta

Annual Cash Flow Statements for Embecta

Quarterly Cash Flow Statements for Embecta

Annual Balance Sheets for Embecta

Quarterly Balance Sheets for Embecta

Annual Metrics And Ratios for Embecta

Quarterly Metrics And Ratios for Embecta

Frequently Asked Questions About Embecta's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools